Cargando…
Analysis and Augmentation of the Immunologic Bystander Effects of CAR T Cell Therapy in a Syngeneic Mouse Cancer Model
The therapeutic efficacy of adoptive transfer of T cells transduced with chimeric antigen receptors (CARs) has been limited in the treatment of solid cancers, partly due to tumor antigen heterogeneity. Overcoming lack of universal tumor antigen expression would be achieved if CAR T cells could induc...
Autores principales: | Klampatsa, Astero, Leibowitz, Michael S., Sun, Jing, Liousia, Maria, Arguiri, Evguenia, Albelda, Steven M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417672/ https://www.ncbi.nlm.nih.gov/pubmed/32802940 http://dx.doi.org/10.1016/j.omto.2020.07.005 |
Ejemplares similares
-
Current Advances in CAR T Cell Therapy for Malignant Mesothelioma
por: Klampatsa, Astero, et al.
Publicado: (2020) -
Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM)
por: Klampatsa, Astero, et al.
Publicado: (2017) -
Precision-Cut Tumor Slices (PCTS) as an Ex Vivo Model in Immunotherapy Research
por: Dimou, Paraskevi, et al.
Publicado: (2022) -
Armored CAR T-Cells: The Next Chapter in T-Cell Cancer Immunotherapy
por: Hawkins, Elizabeth R, et al.
Publicado: (2021) -
Fibroblast Activation Protein (FAP)-Targeted CAR-T Cells: Launching an Attack on Tumor Stroma
por: Bughda, Reyisa, et al.
Publicado: (2021)